{"title":"Recurrent Anterior Epistaxis in Children With Allergic Rhinitis and Non-Allergic Rhinitis: Clinical Features.","authors":"Linyan Tao, Zhengcai Lou","doi":"10.1177/01455613251342916","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study described the endoscopic characteristics of recurrent anterior epistaxis (RAE) with and without allergic rhinitis (AR), and the outcomes of treatment with mupirocin ointment.</p><p><strong>Material and methods: </strong>Children with RAE were examined using nasal endoscopy, serum specific immunoglobulin E antibodies, and skin-prick test. The children were divided into AR (RAE with AR) and non-AR (RAE without AR) groups. All children received mupirocin ointment topically twice daily for 4 weeks. Recurrent epistaxis and epistaxis severity scores were compared at 2, 4, and 12 weeks of follow-up.</p><p><strong>Results: </strong>A total of 326 patients with 432 nostrils with RAE were included; 76.4% of patients had the bad habit of frequent nose-picking or rubbing. Of the 178 nostrils in the AR group, diffuse telangiectasia was found in 89.3%, scattered telangiectasia in 8.4%, and mucosal ulceration in 2.3%. Of the 254 nostrils in the non-AR group, the endoscopic findings of the anterior septum in the bleeding nostrils included mucosal ulceration in 77.6%, scattered telangiectasia in 17.7%, isolated punctate telangiectasias in 3.1%, and diffuse telangiectasia in 1.6%. In addition, the prevalence of mucosal crusts in the non-AR group was significantly higher than in the AR group (76.8% vs 20.8%), whereas the prevalence of severe hypertrophic inferior turbinates or nasal secretion was significantly higher in the AR group. The prevalence of recurrent epistaxis was significantly higher in the AR group than in the non-AR group at 2 (71.3% vs 57.7%), 4 (65.7% vs 37.8%), and 12 (78.1% vs 43.5%) weeks post-treatment.</p><p><strong>Conclusions: </strong>AR was common in children with RAE, with prominent diffuse telangiectasia evident by endoscopy in most, while most non-AR RAE children had mucosal ulceration or scattered telangiectasia. Compared with outcomes in non-AR RAE children, the efficacy of mupirocin ointment in the treatment of RAE with AR was not satisfactory.</p>","PeriodicalId":93984,"journal":{"name":"Ear, nose, & throat journal","volume":" ","pages":"1455613251342916"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ear, nose, & throat journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/01455613251342916","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: This study described the endoscopic characteristics of recurrent anterior epistaxis (RAE) with and without allergic rhinitis (AR), and the outcomes of treatment with mupirocin ointment.
Material and methods: Children with RAE were examined using nasal endoscopy, serum specific immunoglobulin E antibodies, and skin-prick test. The children were divided into AR (RAE with AR) and non-AR (RAE without AR) groups. All children received mupirocin ointment topically twice daily for 4 weeks. Recurrent epistaxis and epistaxis severity scores were compared at 2, 4, and 12 weeks of follow-up.
Results: A total of 326 patients with 432 nostrils with RAE were included; 76.4% of patients had the bad habit of frequent nose-picking or rubbing. Of the 178 nostrils in the AR group, diffuse telangiectasia was found in 89.3%, scattered telangiectasia in 8.4%, and mucosal ulceration in 2.3%. Of the 254 nostrils in the non-AR group, the endoscopic findings of the anterior septum in the bleeding nostrils included mucosal ulceration in 77.6%, scattered telangiectasia in 17.7%, isolated punctate telangiectasias in 3.1%, and diffuse telangiectasia in 1.6%. In addition, the prevalence of mucosal crusts in the non-AR group was significantly higher than in the AR group (76.8% vs 20.8%), whereas the prevalence of severe hypertrophic inferior turbinates or nasal secretion was significantly higher in the AR group. The prevalence of recurrent epistaxis was significantly higher in the AR group than in the non-AR group at 2 (71.3% vs 57.7%), 4 (65.7% vs 37.8%), and 12 (78.1% vs 43.5%) weeks post-treatment.
Conclusions: AR was common in children with RAE, with prominent diffuse telangiectasia evident by endoscopy in most, while most non-AR RAE children had mucosal ulceration or scattered telangiectasia. Compared with outcomes in non-AR RAE children, the efficacy of mupirocin ointment in the treatment of RAE with AR was not satisfactory.
目的:本研究描述了伴有和不伴有变应性鼻炎(AR)的复发性前鼻出血(RAE)的内镜特征,以及莫匹罗星软膏治疗的结果。材料与方法:采用鼻内镜、血清特异性免疫球蛋白E抗体、皮肤点刺试验对RAE患儿进行检测。将患儿分为AR组(RAE合并AR)和非AR组(RAE不合并AR)。所有儿童均局部使用莫匹罗星软膏,每日两次,持续4周。在随访2周、4周和12周时比较复发性鼻出血和鼻出血严重程度评分。结果:共纳入326例432鼻孔RAE患者;76.4%的患者有频繁抠鼻或揉鼻的不良习惯。在AR组178个鼻孔中,弥漫性毛细血管扩张占89.3%,分散性毛细血管扩张占8.4%,粘膜溃疡占2.3%。在非ar组的254个鼻孔中,出血鼻孔前隔的内镜检查结果包括77.6%的粘膜溃疡,17.7%的分散毛细血管扩张,3.1%的孤立点状毛细血管扩张,1.6%的弥漫性毛细血管扩张。此外,非AR组粘膜结痂的患病率显著高于AR组(76.8% vs 20.8%),而重度下鼻甲肥大或鼻分泌物的患病率显著高于AR组。在治疗后2周(71.3% vs 57.7%)、4周(65.7% vs 37.8%)和12周(78.1% vs 43.5%), AR组鼻出血复发率显著高于非AR组。结论:AR在RAE患儿中较为常见,多数内镜下可见明显弥漫性毛细血管扩张,而非AR的RAE患儿多为粘膜溃疡或分散毛细血管扩张。与非AR的RAE患儿的结局相比,莫匹罗星软膏治疗RAE合并AR的疗效并不令人满意。